Skip to main content

ACQC · Relativity Acquisition Corp · Investor Relations

Track ACQC — free
$16.00 At close · Jul 23
Market Cap
$68.85M
Shares
4.30M
Volume · Jul 23 8338 Avg daily vol (2 sessions) 4244

Press releases and events scraped from the company’s investor relations website. Past events open our own call or event page when we host one; otherwise listings link to the original source.

Recent news

Date Headline
2026-07-28 Instinct Bio (Nasdaq: BIOT) Secures $150 Million Equity Funding to Advance Regenerative Medicine Platform and Strategic Growth
2026-07-23 Instinct Bio Completes Business Combination with Relativity Acquisition Corp. and Makes Its Nasdaq Debut Under the Ticker “BIOT” on July 24, 2026
2026-03-25 Relativity Acquisition Corp. Shareholders Approve Business Combination with Instinct Brothers
2026-03-11 Relativity Acquisition Corp. and Instinct Brothers Announce Extraordinary General Meeting of Relativity Shareholders to Approve Business Combination
2025-11-12 Relativity Acquisition Corp. SPAC and Instinct Bio Technical Co. Announce Effectiveness of Registration Statement
2025-09-15 Relativity Acquisition Corp. Announces the Public Filing of a Registration Statement on Form F-4 for Instinct Bio Technical Company Inc.
2025-09-12 Instinct Brothers Co., Ltd, a Japanese Vertically Integrated Regenerative Medicine & Stem Cell Technology Company, to Go Public via Merger with Relativity Acquisition Corp.
2024-04-29 Relativity Acquisition Corp. Announces Receipt of Nasdaq Delisting Determination
2023-11-09 Relativity Acquisition Corp. Announces Funding and Extension of Deadline to Complete Business Combination
2023-08-15 Relativity Acquisition Corp. Announces Confidential Submission of Registration Statement on Form S-4 Related to Proposed Merger with SVES
2023-08-07 Relativity Acquisition Corp. Announces Funding and Extension of Deadline to Complete Business Combination
2023-02-13 SVES, an Off-Price Apparel Distribution Company, Announces Plans to Go Public via Merger with Relativity Acquisition Corp.
Key facts CIK 1860484 CUSIP 75944B106 Visit website